Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities
Net loss	$ (4,836,923)	$ (2,259,483)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	0	484
Change in fair value of warrant liabilities	(1,312,899)	1,125,189
Stock-based compensation expense	44,679	0
Changes in operating assets and liabilities:
Deferred cost	0	(1,680,954)
Prepaid expenses	(302,123)	0
Accounts payable	(587,263)	1,236,556
Accrued interest	0	228,937
Accrued expenses and other current liabilities	228,220	218,236
Net cash used in operating activities	(6,766,309)	(1,131,035)
Cash flows from financing activities
Issuance of common stock in lieu of deferred compensation	0	424,100
Proceeds from issuance of Units in public offering, net	31,497,463	0
Proceeds from issuance of convertible promissory notes	0	1,060,000
Net cash provided by financing activities	31,497,463	1,484,100
Net increase (decrease) in cash	24,731,154	353,065
Cash, beginning of period	8,760,462	193
Cash, end of period	33,491,616	353,258
Supplemental disclosures of cash flow information:
Cash paid for taxes	2,400	0
Deferred offering costs included in accounts payable and other accrued expenses	$ 0	$ 0